These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23240298)

  • 1. [Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy].
    Samaras N; Samaras D; Lang PO; Bridevaux PO; Gex G; Janssens JP; Pichard C
    Rev Med Suisse; 2012 Nov; 8(363):2224-7. PubMed ID: 23240298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
    Velema MS; Kwa BH; de Ronde W
    Curr Opin Pulm Med; 2012 Mar; 18(2):118-24. PubMed ID: 22189453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low testosterone in chronic obstructive pulmonary disease: does it really matter?
    Laghi F
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1069-70. PubMed ID: 16249319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypogonadism and chronic obstructive pulmonary disease].
    Vertkin AL; Morgunov LIu; Shakhmanaev KhA
    Urologiia; 2013; (5):116-8, 120-2. PubMed ID: 24437255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects.
    Balasubramanian V; Naing S
    Curr Opin Pulm Med; 2012 Mar; 18(2):112-7. PubMed ID: 22234275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and chronic obstructive pulmonary disease.
    Svartberg J
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):257-61. PubMed ID: 20125007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.
    Casaburi R; Bhasin S; Cosentino L; Porszasz J; Somfay A; Lewis MI; Fournier M; Storer TW
    Am J Respir Crit Care Med; 2004 Oct; 170(8):870-8. PubMed ID: 15271690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral muscle dysfunction in chronic obstructive pulmonary disease].
    Maltais F; Leblanc P; Jobin J; Casaburi R
    Rev Mal Respir; 2002 Sep; 19(4):444-53. PubMed ID: 12417861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease.
    Mainguy V; Girard D; Maltais F; Saey D; Milot J; Sénéchal M; Poirier P; Provencher S
    Am J Cardiol; 2012 Jul; 110(2):258-63. PubMed ID: 22497677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients.
    Altenburg WA; de Greef MH; ten Hacken NH; Wempe JB
    Respir Med; 2012 May; 106(5):694-700. PubMed ID: 22154126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testosterone and chronic obstructive pulmonary disease].
    Slim A; Hedhli A; Ouahchi Y; Toujani S; Cheikh Rouhou S; Hadj Taeib S; Mjid M; Merai S; Feki M
    Rev Mal Respir; 2020 Dec; 37(10):790-799. PubMed ID: 33067077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testosterone treatment of sarcopenia].
    Stárka L
    Vnitr Lek; 2006 Oct; 52(10):909-11. PubMed ID: 17063802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
    Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
    J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone supplementation for aging-associated sarcopenia.
    Bhasin S
    J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1002-8. PubMed ID: 14630881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle dysfunction in chronic obstructive pulmonary disease.
    Casaburi R
    Med Sci Sports Exerc; 2001 Jul; 33(7 Suppl):S662-70. PubMed ID: 11462075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a pulmonary rehabilitation programme on older patients with chronic pulmonary disease.
    Kyung KA; Chin PA
    J Clin Nurs; 2008 Jan; 17(1):118-25. PubMed ID: 17394540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR; Chen RC
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of the treatment of chronic obstructive pulmonary disease in men with androgen deficiency].
    Vertkin AL; Shakhmanaev AA
    Klin Med (Mosk); 2014; 92(11):38-42. PubMed ID: 25796945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.